Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: A case report

Journal of Clinical Psychopharmacology

Volumn 34, Issue 5, 2014, Pages 649-651

  De Berardis, Domenico ^a,b   Campanella, Daniela ^a   Serroni, Nicola ^a   Rapini, Gabriella ^a   Olivieri, Luigi ^a   Fornaro, Michele ^c   Valchera, Alessandro ^d   Iasevoli, Felice ^e   Napoletano, Cosimo ^f   Martinotti, Giovanni ^b   Giannantonio, Massimo Di ^b  

^a National Health Trust   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Hermanas Hospitalarias   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Cardiovascular Department Hospital G Mazzini Teramo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; C REACTIVE PROTEIN; CLOZAPINE; CREATINE KINASE; FIBRINOGEN; HALOPERIDOL; INDOMETACIN; RISPERIDONE; TROPONIN T; VALPROIC ACID; NEUROLEPTIC AGENT;

ADULT; BEDTIME DOSAGE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EOSINOPHIL; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTHERMIA; LETTER; LEUKOCYTE DIFFERENTIAL COUNT; MALE; MEDICAL HISTORY; MEDICATION COMPLIANCE; MORNING DOSAGE; PERICARDIAL EFFUSION; PERICARDITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; SCHIZOPHRENIA; SEIZURE; SINUS TACHYCARDIA; ST SEGMENT; TACHYCARDIA; THORAX PAIN; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; DRUG RESISTANCE;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; INDOMETHACIN; MALE; PERICARDITIS; SCHIZOPHRENIA; VALPROIC ACID;

EID: 84907423441     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000179     Document Type: Letter

References (16)

1. Meltzer HY. Clozapine: balancing safety with superior antipsychotic efficacy. Clin Schizophr Relat Psychos. 2012;6:134-144.
2. De Berardis D, Serroni N, Campanella D, et al. Update on the adverse effects of clozapine: focus on myocarditis. Curr Drug Saf. 2012;7:55-62.
3. Htwe TH, Khardori NM. Cardiac emergencies: infective endocarditis, pericarditis, and myocarditis. Medi Clin North Am. 2012;96:1149-1169.
4. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
5. Ronaldson KJ, Fitzgerald PB, Taylor AJ, et al. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study. Schizophr Res. 2012;141:173-178.
6. Ronaldson KJ, Fitzgerald PB, Taylor AJ, et al. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases. Schizophr Res. 2011;128: 161-165.
7. Fernandez-Perez R, Alvarez-Dobano JM, Suarez-Antelo J, et al. Eosinophilic pleural effusion associated with the addition of sodium valproate. J Clin Psychopharmacol. 2009;29:310-311.
8. Facciola G, Avenoso A, Scordo MG, et al. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Ther Drug Monit. 1999;21:341-345.
9. Wehmeier PM, Heiser P, Remschmidt H. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. J Clin Pharm Ther. 2005; 30:91-96.
10. Raju P, Rao GK, Davis G. Pericardial effusion in patients with schizophrenia: are they on clozapine? Emerg Med J. 2008;25:383-384.
11. Daly JM, Goldberg RJ, Braman SS. Polyserositis associated with clozapine treatment. Am J Psychiatry. 1992;149:1274-1275.
12. Rathore S, Masani ND, Callaghan PO. Clozapine-induced effuso-constrictive pericarditis. Case report and review of the literature. Cardiology. 2007;108:183-185.
13. Kortner K, Neuhaus AH, Schurer F, et al. Eosinophilia indicating subclinical clozapine-induced pericarditis. J Clin Psychiatry. 2007;68:1147-1148.
14. Albouaini K, Ruzsics B, Chenzbraun A. Multimodality cardiac imaging in clozapine-induced eosinophilic constrictive perimyocarditis. Eur Heart J Cardiovasc Imaging. 2013; 14:338.
15. Ronaldson KJ, Fitzgerald PB, Taylor AJ, et al. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry. 2011;45:458-465.
16. Reinders J, Parsonage W, Lange D, et al. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Aust N Z J Psychiatry. 2004;38: 915-922.